These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38813792)

  • 21. Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame.
    Thompson KM; Kalkowska DA
    Risk Anal; 2021 Feb; 41(2):229-247. PubMed ID: 32339327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polio eradication initiative in Afghanistan, 1997-2013.
    Simpson DM; Sadr-Azodi N; Mashal T; Sabawoon W; Pardis A; Quddus A; Garrigos C; Guirguis S; Zahoor Zaidi SS; Shaukat S; Sharif S; Asghar H; Hadler SC
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S162-72. PubMed ID: 25316832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress toward poliomyelitis eradication - Nigeria, January 2011-September 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Nov; 61(44):899-904. PubMed ID: 23134973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polio Eradication and Endgame Plan - Victory within Grasp.
    Patel M; Menning L; Bhatnagar P
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S28-S32. PubMed ID: 27771636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The new polio eradication end game: rationale and supporting evidence.
    Sutter RW; Platt L; Mach O; Jafari H; Aylward RB
    J Infect Dis; 2014 Nov; 210 Suppl 1():S434-8. PubMed ID: 25316865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of disruptions caused by the COVID-19 pandemic on global polio eradication.
    Kalkowska DA; Voorman A; Pallansch MA; Wassilak SGF; Cochi SL; Badizadegan K; Thompson KM
    Vaccine; 2023 Apr; 41 Suppl 1():A12-A18. PubMed ID: 33962838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Updated Economic Analysis of the Global Polio Eradication Initiative.
    Thompson KM; Kalkowska DA
    Risk Anal; 2021 Feb; 41(2):393-406. PubMed ID: 33590521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.
    Ramirez Gonzalez A; Farrell M; Menning L; Garon J; Everts H; Hampton LM; Dolan SB; Shendale S; Wanyoike S; Veira CL; Châtellier GMD; Kurji F; Rubin J; Boualam L; Chang Blanc D; Patel M
    J Infect Dis; 2017 Jul; 216(suppl_1):S183-S192. PubMed ID: 28838179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polio Endgame, Information Gaps Related to Vaccines and Immunity.
    Ahmad M; Bahl S; Kunwar A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S33-S37. PubMed ID: 27771637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress toward poliomyelitis eradication - Nigeria, January 2012-September 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1009-13. PubMed ID: 24336134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
    Yehualashet YG; Horton J; Mkanda P; Vaz RG; Afolabi O; Gashu SG; Banda R; O'Malley H; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress toward polio eradication - worldwide, 2014-2015.
    Hagan JE; Wassilak SG; Craig AS; Tangermann RH; Diop OM; Burns CC; Quddus A;
    MMWR Morb Mortal Wkly Rep; 2015 May; 64(19):527-31. PubMed ID: 25996095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
    Patel M; Cochi S
    J Infect Dis; 2017 Jul; 216(suppl_1):S1-S8. PubMed ID: 28838196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine.
    Voorman A; Lyons H; Bennette C; Kovacs S; Makam JK; F Vertefeuille J; Tallis G
    Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A85-A92. PubMed ID: 35339308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential impact of expanding target age groups for polio immunization campaigns.
    Duintjer Tebbens RJ; Kalkowska DA; Wassilak SG; Pallansch MA; Cochi SL; Thompson KM
    BMC Infect Dis; 2014 Jan; 14():45. PubMed ID: 24472313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress Toward Polio Eradication - Worldwide, January 2019-June 2021.
    Bigouette JP; Wilkinson AL; Tallis G; Burns CC; Wassilak SGF; Vertefeuille JF
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1129-1135. PubMed ID: 34437527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress toward polio eradication--Somalia, 1998-2013.
    Mbaeyi C; Kamadjeu R; Mahamud A; Webeck J; Ehrhardt D; Mulugeta A
    J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S173-80. PubMed ID: 25316833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the impact of polio supplementary immunisation activities on routine immunisation and health systems: a systematic review.
    Vassallo A; Dunbar K; Ajuwon B; Lowbridge C; Kirk M; King C; Sheel M
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34776411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs.
    Duintjer Tebbens RJ; Thompson KM
    BMC Infect Dis; 2015 Sep; 15():390. PubMed ID: 26404780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication.
    Modlin JF; Bandyopadhyay AS; Sutter R
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S398-S404. PubMed ID: 34590135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.